marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Revolution Medicines Financial Statements 2011-2024 | RVMD
Annual Financial Statements Revolution Medicines
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.44 B | 1.99 B | 1.57 B | 2.31 B | - | - | - | - | - | - | - | - | - |
Shares |
113 M | 80.6 M | 72.8 M | 54.9 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
30.4 | 24.6 | 21.5 | 42.1 | - | - | - | - | - | - | - | - | - |
Net Income |
-436 M | -249 M | -187 M | -108 M | -47.7 M | -41.8 M | -31.1 M | - | - | - | - | - | - |
Revenue |
11.6 M | 35.4 M | 29.4 M | 43 M | 50 M | 20.2 M | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-487 M | -258 M | -188 M | -111 M | -54.1 M | -40.3 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | 71 K | 106 K | 116 K | - | - | - | - | - | - | - |
EBITDA |
-482 M | -254 M | -185 M | -108 M | -50.8 M | -38.6 M | -29.8 M | - | - | - | - | - | - |
Operating Expenses |
499 M | 294 M | 217 M | 154 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
75.6 M | 40.6 M | 30.4 M | 21.4 M | 12.4 M | 9.41 M | 4.54 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Revolution Medicines
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
167 M | 165 M | 165 M | 165 M | 109 M | 107 M | 94.8 M | 90.4 M | 84.7 M | 74.3 M | 74.2 M | 74.1 M | 73.5 M | 73.4 M | 70.4 M | 66.6 M | 64.9 M | 58.8 M | 29.3 M | 3.29 M | 2.81 M | 2.72 M | 2.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-156 M | -133 M | -116 M | - | -108 M | -98.3 M | -68.1 M | - | -73.3 M | -61.2 M | -57.6 M | - | -52.9 M | -44.3 M | -37.2 M | -34.2 M | -27.2 M | -27.2 M | -19.5 M | -14.6 M | -12.8 M | -10.1 M | -10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | 3.82 M | 7.01 M | - | 3.36 M | 9.12 M | 7.58 M | - | 1.1 M | 8.7 M | 10.1 M | 8.75 M | 12.7 M | 10 M | 11.5 M | 12.1 M | 12.5 M | 12.3 M | 13.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-176 M | -157 M | -141 M | - | -123 M | -109 M | -75.2 M | - | -76.5 M | -62.1 M | -57.9 M | - | -53.2 M | -44.5 M | -37.4 M | - | -27.6 M | -28 M | -21.1 M | - | -13.6 M | -10.6 M | -10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
282 K | 16 K | - | - | - | - | - | - | - | - | - | - | - | - | 12 K | - | 17 K | 19 K | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-174 M | -155 M | -139 M | - | -122 M | -108 M | -74 M | - | -75.5 M | -61.2 M | -57 M | - | -50.9 M | -43.1 M | -36.7 M | - | -25.6 M | -26.7 M | -20.4 M | - | -11.9 M | -9.49 M | -9.91 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
176 M | 157 M | 141 M | - | 123 M | 113 M | 82.2 M | - | 79.9 M | 71.2 M | 65.5 M | - | 54.3 M | 53.2 M | 47.5 M | - | 40.2 M | 38 M | 32.6 M | - | 26.1 M | 22.8 M | 23.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
24 M | 21.7 M | 22.8 M | - | 15.5 M | 14.6 M | 13.2 M | - | 10.4 M | 10.2 M | 9.04 M | - | 7.79 M | 7.3 M | 6.67 M | - | 5.34 M | 5.09 M | 5.17 M | - | 3.1 M | 2.72 M | 2.42 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency